Psychopharmacologic treatment of refractory pediatric obsessive compulsive disorder.

J Child Adolesc Psychopharmacol

Wake Forest University School of Medicine, Wake Forest Baptist Health, Department of Psychiatry/Section of Child and Adolescent Psychiatry, Winston Salem, North Carolina.

Published: September 2013

Download full-text PDF

Source
http://dx.doi.org/10.1089/cap.2013.0025DOI Listing

Publication Analysis

Top Keywords

psychopharmacologic treatment
4
treatment refractory
4
refractory pediatric
4
pediatric obsessive
4
obsessive compulsive
4
compulsive disorder
4
psychopharmacologic
1
refractory
1
pediatric
1
obsessive
1

Similar Publications

Health-promoting lifestyle and behaviors play a crucial role in the prognosis of an illness as well as in healing. With the significant global burden of unhealthy lifestyle choices, their impact on individuals with substance use disorders can be particularly burdensome, hampering overall well-being. This study assesses health-promoting lifestyle and behavior and dietary habits among treatment-seeking male patients with opioid use disorders.

View Article and Find Full Text PDF

The Experience Sampling Method (ESM) is increasingly used to validate and assess treatment effects. We conducted a systematic review to update, and extend, the previous review by Bos et al. (2015), by performing literature searches in PubMed, PsycInfo, and EMBASE.

View Article and Find Full Text PDF

Objective: To assess the accuracy of a large language model (LLM) in measuring clinician adherence to practice guidelines for monitoring side effects after prescribing medications for children with attention-deficit/hyperactivity disorder (ADHD).

Methods: Retrospective population-based cohort study of electronic health records. Cohort included children aged 6 to 11 years with ADHD diagnosis and 2 or more ADHD medication encounters (stimulants or nonstimulants prescribed) between 2015 and 2022 in a community-based primary health care network (n = 1201).

View Article and Find Full Text PDF

Introduction: Most psychiatric inpatients receive psychopharmacological treatment indicated for their mental diseases. The aim of this systematic review is to give clinical pharmacists and physicians a comprehensive summary of common drug-related problems (DRPs) in adult psychiatric inpatients and of potential interventions to solve them in clinical practice.

Methods: Six databases and registers were searched for English, German and French articles published between 1999 and 2023 with content regarding the prevalence and/or type or interventions to solve DRPs in adult psychiatric inpatients.

View Article and Find Full Text PDF

[Living with psychotropic drugs: A community photovoice study in people with high treatment adherence in Southeastern Spain].

Salud Colect

October 2024

Doctora en Medicina. Catedrática de Medicina Preventiva y Salud Pública, Área de Medicina Preventiva y Salud Pública, Universidad de Alicante, Alicante, España. Área de Epidemiología y Salud Pública, Centro de Investigación Biomédica en Red (CIBERESP), Madrid, España.

Adherence to psychopharmacological treatment essentially involves a process of meaning-making. The objective of this study was to explore the experience of people undergoing chronic psychiatric treatment from the patients' perspective. In 2018, using the photovoice methodology, four sessions were conducted with the participation of 11 individuals from a community school in a socially marginalized neighborhood of a southeastern Spanish city, some of whom were also users of a social rehabilitation and integration center and a day center.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!